IDL Biotech second quarter report 2018 | IDL Biotech
IDL Biotech

CLOSE MENU

August 2018

IDL Biotech second quarter report 2018

Gunnar Wahlberg appointed as acting CEO

The Board has appointed Gunnar Wahlberg as acting CEO.

Charlotte Berg leaves the position as CEO of IDL Biotech AB (publ)

IDL Biotech's CEO, Charlotte Berg, has informed the Board that, after more than ten years at the company, she wishes to resign as CEO to start another assignment in a non-competing company.

IDL Biotech

Skip this intro